by David Kent | May 2, 2012
Anticipatory ethics and the problem of expectations One of my favorite things about Canadian Stem Cell Network meetings (now renamed the Till and McCulloch Meetings) is the integration into the main programming of Ethical, Legal, and Social Issues (ELSI). It...
by Stem Cell Network | Mar 5, 2012
by Lisa Willemse, with Ubaka Ogbogu and Timothy Caulfield The announcement last week that a team of researchers had identified stem cells responsible for generating human eggs caused a ripple of excitement for several reasons. Not only does the news end a controversy...
by David Kent | Feb 29, 2012
Last week I attended a breakfast at Eversheds, a law firm in Cambridge entitled Stem cell patenting, Brüstle v Greenpeace: business breaker or business as usual? which focused on the practical implications of the recent decision from the Court of Justice of the...
by Stem Cell Network | Jan 17, 2012
In recent years, the research community has been quite outspoken in its condemnation of rogue stem cell clinics operating in many countries across the globe. Indeed, through announcements made by health and related ministries in China, India and the US, it appears the...
by David Kent | Jan 12, 2012
Last fall, I wrote on the Eurostemcell documentary film entitled Stem Cell Revolutions: A Vision of the Future, which featured some experimental stem cell treatments in India, and since that time, I have tried to keep my finger on the pulse of what has been happening...
by Lisa Willemse | Dec 21, 2011
In a traditional view of medical research, advances tend to be measured against the overarching goal of cure. Noble as this might be, research is rarely such a black and white affair — if we have learned anything, it’s that there are innumerable shades of grey....
Comments